Colombia's Constitutional Court ordered the Ministry of Health and health service providers to ensure universal heel prick screening—a preventive blood test performed on newborns within 48–72 hours of birth to detect serious metabolic and endocrine disorders—reaches 100% coverage by 2027. The ruling stemmed from a case where a family was denied the test, leading the court to find that hospitals and health insurers had violated the child's right to preventive healthcare and to mandate automatic, mandatory screening for all newborns.